Journal of Translational Medicine
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
ResearchIn situ analysis of FOXP3+ regulatory T cells in human colorectal cancerChristoph Loddenkemper1 , Martin Schernus2 , Michel Noutsias3 , Harald Stein1 , Eckhard Thiel2 and Dirk Nagorsen2  1
Department of Pathology, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany 2
Department of Hematology, Oncology, and Transfusion Medicine, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany 3
Department of Cardiology and Pneumonology, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany author email corresponding author email
Journal of Translational Medicine 2006,
4:52doi:10.1186/1479-5876-4-52
|
| Published: |
13 December 2006 |
Abstract
The immune system spontaneously responds to tumor-associated antigens in peripheral blood of colorectal cancer (CRC) patients. Regulatory T cells (Treg) are suspected of influencing the interaction between the tumor and immune system and thus the course of malignant diseases. However, the function of Tregs in the development of T cell responses and on the clinical course of CRC is not clear. We analyzed Treg infiltration (FOXP3 staining) in situ in 40 CRC patients and investigated whether there is a correlation to disease stage, systemic T cell response, and survival. Treg infiltration was significantly higher in CRC than in healthy colon. Stromal Treg infiltration was significantly higher than epithelial infiltration in CRC. Furthermore, Treg infiltration in the tumor was significantly higher in limited disease than in metastatic CRC. The average Treg infiltration rate in the tumor was non-significantly higher in patients without systemic TAA-specific T cell response. Survival did not differ between patients with high Treg infiltration and those with low Treg infiltration. In conclusion, a direct link between Treg infiltration in the tumor and the development of a systemic T cell response in CRC cannot be proven. However, local Treg infiltration was significantly higher in limited disease, in which a systemic TAA-directed T cell responses is less frequently observed. |